VistaGen Therapeutics Inc. (NASDAQ: VTGN) Stock Information | RedChip

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Listen to this Section


$3.41
+0.1300 ( +3.96% ) 76.9K

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Market Data


Open


$3.41

Previous close


$3.28

Volume


76.9K

Market cap


$91.45M

Day range


$3.30 - $3.46

52 week range


$2.45 - $7.35

Insider Ownership Transactions

Total Amount Purchased: -1,010,971.00 | $ -3,447,411.11

Date Type Amount Purchased Purchaser
2024-07-02 Sale -4854.00 Singh Shawn
2024-07-02 Sale -4854.00 Adler Reid G.
2024-07-02 Sale -2671.00 Prince Joshua S.
2024-07-02 Sale -3592.00 Anderson Cynthia Lynn
2024-06-26 Sale -170000.00 Adler Reid G.
2024-06-26 Sale -150000.00 Prince Joshua S.
2024-06-26 Sale -150000.00 Anderson Cynthia Lynn
2024-06-26 Sale -500000.00 Singh Shawn
2024-03-06 Sale -12500.00 FitzPatrick Margaret M
2024-03-06 Sale -12500.00 Curley Joanne

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 58 Aug 13, 2024
8-k 8K-related 15 Aug 13, 2024
def Proxies and info statements 26 Jul 17, 2024
8-k 8K-related 16 Jul 12, 2024
8-k 8K-related 16 Jul 10, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
4 Insider transactions 1 Jul 02, 2024
8-k 8K-related 16 Jun 28, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.